Adenocarcinomas are by far the most common form of Colorectal Cancer, claiming 95 percent of diagnosal cases. This form of cancer often begins in the inner layer of the bowel before spreading into other, deeper layers. Because of this, early detection and treatment is essential in terms of ensuring that the cancer does not become life threatening.
There are several types of Adenocarcinomas, but the most dangerous are Signet Ring Cell Adenocarcinomas. While these only account for less than one percent of all Adenocarcinomas, they are typically very agressive.
They are very difficult to treat in the vast majority of cases.
This is a very common form of cancer, with well over 100,000 cases occuring each year in the United States alone. While the lethality of this form of cancer varies greatly on the time in which it is detected, an average of 50 percent of patients survive 5 years of more after contracting the disease. Survival rates in patients that achieve early detection are more comforting, with anywhere from 70 to 80 percent of these patients reaching this same milestone. That said, more research is required to ensure that these promising odds are afforded to all Adenocarcinoma patients.
Sarcomas are cancers that develop in the bone or muscle. The growth of this cancer causes pressure on the body and organs that can sometimes result in the infected cells being spread around the body. While they technically have the potential to spread to nearly any site in the body, the most common place to spread is to the lungs or bones.
Like all forms of Colorectal Cancers, early detection is the key to ensuring a quick and efficient treatment. The earlier the cancer is discovered, the less likely it is to have spread, thus allowing for the removal of the cancerous cells through surgeries. However, more complex cases of Sarcoma may mean that radiotherapy and chemotherapy must be used in order to reduce the tumor in size before surgery.
Carcinoids are an especially slow growing form of Colorectal Cancer. While this has the advantage of ensuring that the tumor is not especially fast-acting, it can also make early detection a challenge. Carcinoids often fail to produce symptoms until late in the disease, something which can mean that the tumor is advanced at the time of discovery.
Early detection of Carcinoids can sometimes make treatment a relatively simple manner, with a targeted surgery removing or preventing the further development of the tumor. However, the low-profile nature of the cancer typically means that more advanced treatment plans are necessary, such as through medications, chemotherapy, and radiotherapy. Although recent advancements have yielded improvements in this regard, these treatment plans are often uncomfortable for the patient due to the slew of negative side effects that they involve.
One of the most powerful tools that doctors and researchs have at their disposal to fight Colorectal Cancers is through early detection and prevention. The best way to do this is to grasp a more advanced knowledge of what actually causes the disease in the first place. There have been tremendous improvements made in this regard over the past decade and a half, something that has proven to be very useful in taking those first steps towards overcoming the issue as a whole.
Many of the risk factors that researchers have identified are lifestyle related. These include things such as smoking or the excessive consumption of alchohol. Similarly, becoming overweight or failing to get a proper amount of physical activity can result in an increased risk for Colorectal Cancers. Because many of these factors are based on active choices in lifestyle, this knowledge has granted people everywhere to be more proactive about their health through the prevention of disease.
Other factors are, unfortunately enough, are beyond the control of the individual. Aging is one example of this, as 90 percent of people diagnosed with a form of Colorectal Cancers are above the age of 50. That said, it is still important to maintain a healthy lifestyle to ensure that the risk of contracting this disease is kept as low as possible. And as research continues to progress, scientists hope to uncover new trends that will enable them to take prevention to the next, more controllable, level.
Recent discoveries have done much to allow researchers to utilize various drug combinations in their efforts to boost the survival rate of Colorectal Cancer patients. These drugs provide patients everywhere with more options, something that serves to enhance the comfort and health of those suffering from the disease.
One of these drugs is Irinotecan, which is a chemotherapy drug that specifically attempts to block the action of an enzyme associated with keeping cancer cells in their proper form. Cancer cells typically divide far faster than healthy cells, and thus are more likely to be targeted by the drug. While side effects do exist, Irinotecan has proved itself to be a valuable tool in the arsenal of doctors, and has kept people healthy since its approval by the FDA in 1996.
Another drug recently approved for the treatment of Colorectal Cancers is Eloxatin. While it is typically used in combination with other drugs, the use of Eloxatin has been associated with a whopping 11 percent in 5-year survival rates in some cases. It is through advancements such as these that we can give hope to those who may otherwise have very little.
Fight Colorectal Cancer has been on the front lines of the fight against Colorectal Cancers for years now. They have dedicated themselves to promoting the development of new treatments as well as making sure the public is well educated on the causes of Colorectal Cancers, something that has done much to inspire hope in those who suffer from it.
They fight against Colorectal Cancers in five main ways: advocacy, awareness generation, providing patients with resources, funding research, and philanthropy. All of these efforts have combined to make them a fortible contender in the fight against this disease. They have managed to do all of this while ensuring financial and ethical transparency, achieving an A+ rating on Charity Navigator in this regard.
In addition to this, they have optained a 4 star rating on Charity Navigator, meaning that all funds donated to them will be allocated responsibly and in a manner that is consistent with those who aim to fight Colorectal Cancers. You can join them in their battle by clicking on the button below to donate.
The NCCRA (National Colorectal Cancer Alliance) has made it their mission to eradicate the threat of Colorectal Cancers for everyone. They attempt to do this by promoting and raising funds for medical screenings, scientific tests, and treatments. They hope that their efforts will one day prove successful enough to yield a cure, and have selflessly pursued this goal since their founding in 2000.
They have raised well over 33 million dollars to date, and have provided thousands of patients with advanced technologies that make their lives more comfortable and fulfilling. One such advancement that they have funded has been the development of a DNA-based stool test that can detect the gene mutation that has been associated with the development of Colorectal Cancers. This provides researchers everywhere with more data with which to construct future treatment plans.
All of this has been accomplished while ensuring a great deal of financial transparency. They keep detailed records as to where donations are directed towards, and maintain a running list of where the most prominent investments lie. It is through such contributions that researchers around the world can harness the tools that they need to make the issue of Colorectal Cancers one of the past. You can help them achieve this goal by clicking on the button below to donate.
The internet has made it possible to join the fight against Colorectal Cancers without spending a single penny. This is the power of word of mouth, the power of sharing our thoughts and ideas to make a change. You can click on the buttons below to get started. Spread the word!